These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 7513607

  • 21. Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.
    Agbotounou WK, Levitzki A, Jacquemin-Sablon A, Pierre J.
    Mol Pharmacol; 1994 May; 45(5):922-31. PubMed ID: 7514714
    [Abstract] [Full Text] [Related]

  • 22. Genistein and tyrphostin 47 stimulate CFTR-mediated Cl- secretion in T84 cell monolayers.
    Sears CL, Firoozmand F, Mellander A, Chambers FG, Eromar IG, Bot AG, Scholte B, De Jonge HR, Donowitz M.
    Am J Physiol; 1995 Dec; 269(6 Pt 1):G874-82. PubMed ID: 8572219
    [Abstract] [Full Text] [Related]

  • 23. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle.
    Di Salvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, Pfitzer G.
    Biochem Biophys Res Commun; 1993 Feb 15; 190(3):968-74. PubMed ID: 8439345
    [Abstract] [Full Text] [Related]

  • 24. Effects of tyrosine kinase inhibitors on protein kinase-independent systems.
    Young SW, Poole RC, Hudson AT, Halestrap AP, Denton RM, Tavaré JM.
    FEBS Lett; 1993 Feb 01; 316(3):278-82. PubMed ID: 8422954
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivatives.
    Markovits J, Larsen AK, Ségal-Bendirdjian E, Fossé P, Saucier JM, Gazit A, Levitzki A, Umezawa K, Jacquemin-Sablon A.
    Biochem Pharmacol; 1994 Aug 03; 48(3):549-60. PubMed ID: 8068042
    [Abstract] [Full Text] [Related]

  • 26. Tyrosine kinase inhibitor-sensitive contractile action of ethanol in gastric smooth muscle: comparison with the action of epidermal growth factor.
    Zheng XL, Hollenberg MD.
    Proc Assoc Am Physicians; 1997 Jan 03; 109(1):78-83. PubMed ID: 9010919
    [Abstract] [Full Text] [Related]

  • 27. Treatment of Ras-induced cancers by the F-actin cappers tensin and chaetoglobosin K, in combination with the caspase-1 inhibitor N1445.
    Tikoo A, Cutler H, Lo SH, Chen LB, Maruta H.
    Cancer J Sci Am; 1999 Jan 03; 5(5):293-300. PubMed ID: 10526670
    [Abstract] [Full Text] [Related]

  • 28. Adenovirus-mediated gene transfer of dominant negative ras(asn17) in 3T3L1 adipocytes does not alter insulin-stimulated P13-kinase activity or glucose transport.
    Gnudi L, Frevert EU, Houseknecht KL, Erhardt P, Kahn BB.
    Mol Endocrinol; 1997 Jan 03; 11(1):67-76. PubMed ID: 8994189
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Tropomyosin-2 cDNA lacking the 3' untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblasts.
    Janssen RA, Mier JW.
    Mol Biol Cell; 1997 May 03; 8(5):897-908. PubMed ID: 9168473
    [Abstract] [Full Text] [Related]

  • 37. A role for Ras in v-Crk transformation.
    Greulich H, Hanafusa H.
    Cell Growth Differ; 1996 Nov 03; 7(11):1443-51. PubMed ID: 8930393
    [Abstract] [Full Text] [Related]

  • 38. Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes.
    Kuo ML, Yang NC.
    Biochem Biophys Res Commun; 1995 Jul 26; 212(3):767-75. PubMed ID: 7626110
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Differential induction of apoptosis in oncogene-transformed NIH 3T3 cells by methylmethanesulfonate.
    Kuo ML, Chou YW, Chau YP, Meng TC.
    Biochem Pharmacol; 1996 Aug 09; 52(3):481-8. PubMed ID: 8687503
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.